医药生物行业跟踪周报:银屑病口服TYK2/IL23双雄并立格局确立 建议关注益方生物 诺诚健华 海思科等

东吴证券
Dec 23

本周、年初至今A 股医药指数涨幅分别为-0.14%、14.49%,相对沪深300 的超额收益分别为0.14%、-1.60%;本周、年初至今恒生医疗保健指数涨跌幅分别为-1.77%、65.28%,相对于恒生科技指数跑赢1.05%、41.44%;本周医药商业(+4.94%)、医疗器械(+1.16%)、医疗服务(+0.55%)涨幅居前;化学制药(-1.74%)股价有所下跌;本周A 股涨幅居前华人健康(+...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10